Infection Surveillance Solutions Market
Infection Surveillance Solutions Market Forecasts to 2028 – Global Analysis By Component (Software, Services), End User (Hospitals, Ambulatory Service Centers, Clinics, Specialty Centers, Academic Institutes), and By Geography
|
Years Covered |
2020-2028 |
|
Estimated Year Value (2021) |
US $0.52 BN |
|
Projected Year Value (2028) |
US $1.48 BN |
|
CAGR (2021 - 2028) |
16.0% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Europe |
|
Fastest Growing Market |
North America |
According to Stratistics MRC, the Global Infection Surveillance Solutions Market is accounted for $0.52 billion in 2021 and is expected to reach $1.48 billion by 2028 growing at a CAGR of 16.0% during the forecast period. Infection surveillance systems are deployed to identify infection trends, evaluate and take preventive measures to control them. Infection surveillance systems provide healthcare institutions with accurate information on employee and patient health and surgical databases with real-time monitoring. Hospitals and long-term care facilities are the biggest user groups of infection surveillance systems.
Market Dynamics:
Driver:
Growing occurrences of hospital associated infections (HAIs)
Hospital associated infections in a clinical setting, such as urinary tract infection, pneumonia, and surgical site infections are increasing due to contaminated devices and equipment, bed linens and patient clothing and others. This has prompted healthcare professionals and hospitals to adopt infection surveillance systems to identify possible healthcare associated infections in the duration of patient stay in hospitals and to assist in evaluating preventive measures. These infection surveillance solutions also aid in diagnosing antibiotic resistant organisms (AROs) and infections due to non-sanitized medical devices. The diagnosis of AROs involves data collection of antibiotic susceptibility test results and correlation of this data with geographical and clinical data for patient populations from whom pathogens were isolated, resulting in detecting an epidemic and facilitating necessary formulations.
Restraint:
Improper data management
Inadequate data management leads to insufficient and incorrect data of patient’s medical history and care, which results in inappropriate inferences in surveillance systems. This might lead to difficulty in timely processing of patient data and their surgical history, and this is a factor expected to adversely affect growth of the infection surveillance market globally to a certain extent over the next few years. Increasing volume of data for analysis from different sources such as Enterprise Risk Management (ERM) and HR software along with changing regulatory requirements to calculate and analyze data decreases the efficiency of infection surveillance systems to accurately identify potential infections in patients.
Opportunity:
Growing advancement in IT infrastructure
Rising capacity of IT systems to perform analytic processing coupled with technological advancements in IT systems is aiding in developing analytical and infection surveillance solutions for application in the healthcare industry. These solutions include usage of algorithms with electronic medical records, specialized data mining software, and fully automated HAI surveillance by employing clinical support based knowledge that helps in identification of certain clinical terms. Various developments in surveillance solutions is making it simpler for health and clinical setting staff to better understand surveillance software and its usage, which results in creating a skilled workforce in the healthcare industry.
Threat:
High interoperability costs
The cost of deployment and interoperability of software solutions is considerably high. The small healthcare organizations struggle to implement internet connectivity to utilize healthcare IT solutions. This is mainly due to difficulties in implementing multiple networks with health setups, a lack of wireless connectivity options, and the need to install subsequent myriads of security layers to avoid data breaches. Infection surveillance software is high priced. And most systems need to be customized with respect to the requirements of healthcare facilities. In addition, support and maintenance services, which include modification and upgrading software as per the changing user requirements, represent a recurring expenditure, which accounts for a large share of the total cost of ownership.
The hospitals segment is expected to be the largest during the forecast period
The hospitals segment is estimated to have a lucrative growth owing to the large patient volume, the increasing incidence of HAIs, and the increasing cases of SSIs. The COVID-19 pandemic has also increased the adoption of infection surveillance solutions in hospitals. The enhanced capacity of IT systems in the analytics is benefiting the development of the market. Hospitals have emerged as the leading end-user in these locations owing to their high adoption rate to maintain electronic healthcare records and managing the real-time pharmacy.
The services segment is expected to have the highest CAGR during the forecast period
The services segment is anticipated to witness the fastest CAGR growth during the forecast period due to the rising demand for product support and maintenance services sub segment. The product support and maintenance services take care of interoperability and software complexity issues. These services ensure that clients (healthcare providers) obtain access to the vendor company’s technical knowledge base and acquire application management skills. These factors are driving the growth of the product support and maintenance services segment.
Region with highest share:
Europe is projected to hold the largest market share during the forecast period owing to the high adaption rate of these surveillance systems, encouraged by the governing authorities in the region. Established players are investing in developing economies to strengthen their regional presence. In addition, the growth of the geriatric population has led to an increase in the incidence of serious diseases, which increases the demand for better sanitation facilities, resulting in increased measures to ensure sanitation in the surrounding area, thus increasing the need for infection control in the upcoming years.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period due to growing R&D activities in the medical sciences. Particularly in the United States of America Health and Human Services (HHS), which is governed by the cabinet-level department of the US federal government is very liberal in funding and maintaining the technological research in medical sciences. Moreover, in the United States, increasing healthcare costs are prompting the individual hospitals to move, or merge with independent healthcare groups to form larger healthcare systems that can broaden their service reach, leverage economies of scale, and also can withstand rising regulatory pressures from the recent government.
Key players in the market
Some of the key players profiled in the Infection Surveillance Solutions Market include Baxter International, Becton Dickson & Company, bioMerieux, Inc., Cerner Corporation, DEB Group Ltd., Emerald Health Information Systems Ltd, Hygreen Inc., Quantros, Inc., Vecna Technologies, Inc., Vigilanz Corporation, Wolters Kluwer N.V., and PeraHealth Inc.
Key Developments:
In June 2021, bioMérieux SA has launched EPISEQ® SARS-COV-2, a genomic software solution to support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants. EPISEQ® SARS-COV-2 is compatible with three major sequencing platforms (Illumina, Oxford Nanopore, Thermo Fisher) and easy to use by any microbiology lab without bioinformatics knowledge or computing resources.
In August 2020, Cerner Corporation collaborated with Xealth, to help health systems choose, manage, and deploy digital tools and applications while offering clinicians access to remote monitoring and more direct engagement with patients.
Components Covered:
• Software
• Services
End Users Covered:
• Hospitals
• Ambulatory Service Centers
• Clinics
• Specialty Centers
• Long-term Care Facilities
• Academic Institutes
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Infection Surveillance Solutions Market, By Component
5.1 Introduction
5.2 Software
5.2.1 Web-based
5.2.2 On-premise
5.3 Services
5.3.1 Training & Consulting
5.3.2 Support & Maintenance
5.3.3 Implementation
6 Global Infection Surveillance Solutions Market, By End User
6.1 Introduction
6.2 Hospitals
6.2.1 Large Hospitals
6.2.2 Medium-sized Hospitals
6.2.3 Small Hospitals
6.3 Ambulatory Service Centers
6.4 Clinics
6.5 Specialty Centers
6.6 Long-term Care Facilities
6.6.1 Homecare Agencies & Hospices
6.6.2 Nursing Homes
6.6.3 Assisted Living Facilities
6.7 Academic Institutes
7 Global Infection Surveillance Solutions Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Baxter International
9.2 Becton Dickson & Company
9.3 bioMerieux, Inc.
9.4 Cerner Corporation
9.5 DEB Group Ltd.
9.6 Emerald Health Information Systems Ltd
9.7 Hygreen Inc.
9.8 Quantros, Inc.
9.9 Vecna Technologies, Inc.
9.10 Vigilanz Corporation
9.11 Wolters Kluwer N.V.
9.12 PeraHealth Inc
List of Tables
1 Global Infection Surveillance Solutions Market Outlook, By Region (2020-2028) ($MN)
2 Global Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
3 Global Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
4 Global Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
5 Global Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
6 Global Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
7 Global Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
8 Global Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
9 Global Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
10 Global Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
11 Global Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
12 Global Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
13 Global Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
14 Global Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
15 Global Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
16 Global Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
17 Global Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
18 Global Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
19 Global Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
20 Global Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
21 Global Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
22 Global Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
23 North America Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
24 North America Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
25 North America Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
26 North America Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
27 North America Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
28 North America Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
29 North America Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
30 North America Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
31 North America Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
32 North America Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
33 North America Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
34 North America Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
35 North America Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
36 North America Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
37 North America Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
38 North America Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
39 North America Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
40 North America Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
41 North America Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
42 North America Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
43 North America Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
44 North America Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
45 Europe Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
46 Europe Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
47 Europe Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
48 Europe Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
49 Europe Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
50 Europe Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
51 Europe Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
52 Europe Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
53 Europe Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
54 Europe Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
55 Europe Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
56 Europe Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
57 Europe Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
58 Europe Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
59 Europe Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
60 Europe Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
61 Europe Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
62 Europe Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
63 Europe Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
64 Europe Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
65 Europe Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
66 Europe Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
67 Asia Pacific Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
68 Asia Pacific Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
69 Asia Pacific Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
70 Asia Pacific Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
71 Asia Pacific Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
72 Asia Pacific Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
73 Asia Pacific Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
74 Asia Pacific Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
75 Asia Pacific Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
76 Asia Pacific Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
77 Asia Pacific Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
78 Asia Pacific Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
79 Asia Pacific Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
80 Asia Pacific Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
81 Asia Pacific Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
82 Asia Pacific Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
83 Asia Pacific Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
84 Asia Pacific Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
85 Asia Pacific Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
86 Asia Pacific Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
87 Asia Pacific Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
88 Asia Pacific Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
89 South America Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
90 South America Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
91 South America Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
92 South America Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
93 South America Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
94 South America Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
95 South America Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
96 South America Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
97 South America Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
98 South America Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
99 South America Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
100 South America Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
101 South America Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
102 South America Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
103 South America Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
104 South America Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
105 South America Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
106 South America Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
107 South America Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
108 South America Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
109 South America Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
110 South America Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
111 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
112 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
113 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
114 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
115 Middle East & Africa Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
116 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
117 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
118 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
119 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
120 Middle East & Africa Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
121 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
122 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
123 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
124 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
125 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
126 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
127 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
128 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
129 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
130 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
131 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
132 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
